A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression
Introduction Repetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment and rTMS protocols have been included in international guidelines for patients with treatment-resistant depression (TRD). The daily administration of standard rTMS protocols, typically over several weeks...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-03-01
|
| Series: | European Psychiatry |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823003115/type/journal_article |
| _version_ | 1827753482220732416 |
|---|---|
| author | L. Larini M. Castiglioni E. Piccoli C. Scarpa M. Renne S. Torriero M. Bosi B. Benatti A. Varinelli M. Vismara B. Dell’Osso |
| author_facet | L. Larini M. Castiglioni E. Piccoli C. Scarpa M. Renne S. Torriero M. Bosi B. Benatti A. Varinelli M. Vismara B. Dell’Osso |
| author_sort | L. Larini |
| collection | DOAJ |
| description |
Introduction
Repetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment and rTMS protocols have been included in international guidelines for patients with treatment-resistant depression (TRD). The daily administration of standard rTMS protocols, typically over several weeks, could be a limiting factor (e.g., time off from work, commuting issues). To intensify the antidepressant response and to reduce the number of stimulation days, it has been proposed that increasing the number of rTMS sessions performed per day could be more effective and help to reduce the burden for patients and clinicians. Although there is much interest in accelerated TMS protocols, little is known about their efficacy and tolerability, and the literature on the topic is still scarce.
Objectives
To compare the efficacy and tolerability of two rTMS protocols (standard vs. accelerated) as augmentative strategies in patients with TRD.
Methods
In the present ongoing, open-label, trial 14 patients meeting DSM-5 criteria for major depressive episode (either unipolar or bipolar), classified as partial responders or non-responders to adequate pharmacological treatment, were randomized to receive either standard (one session per day, five days a week, for four weeks; n= 7) or accelerated (two sessions per day, five days a week, for two weeks; n=6) rTMS treatment protocols. In both cases, rTMS was performed on the left dorsolateral prefrontal cortex, high frequency (10 Hz) at 120% of the motor threshold, 3000 pulses per sessions. Primary outcome measures included HAM-D, MADRS, and CGI-S scores at baseline (T0), at the end of rTMS treatment (T1), and after 1 month (T2), as well as tolerability based on adverse effects. Paired Samples t-Test for continuous variables was used to compare psychometric scales at each timepoint, while t-Test was used to compare differences between the two groups.
Results
With respect to total sample, in terms of primary outcome measures a significant reduction of HAM-D, MADRS and CGI-S total scores between T0 and T1 (t: 3.01, p<0.05; t: 1.692, p<0.5; t:3.207, p<0.05 respectively), T1 and T2 (t: 3.264, p<0.05: t:2.669, p<0.05; t:.085, p=0.437 respectively) and T0 and T2 (t:5.669, p<0.05; t=4.711, p<0.05; t:2.551, p<0.05 respectively) was found. No significant differences in terms of efficacy were found between the two groups. One patient dropped-out for reasons not related to rTMS treatment. Mild and transient headache during the stimulation was the only side effect reported (4 patients).
Image:
Conclusions
Consistently with previous literature studies, our preliminary results supported the evidence of comparable efficacy and tolerability between accelerated and standard rTMS protocols. In the future, larger, blinded, and controlled trials might support these conclusions and further address treatment parameters of novel accelerated rTMS protocols.
Disclosure of InterestNone Declared |
| first_indexed | 2024-03-11T07:35:50Z |
| format | Article |
| id | doaj.art-5a4475ca0c644185b0035f0e68da8ed4 |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:35:50Z |
| publishDate | 2023-03-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-5a4475ca0c644185b0035f0e68da8ed42023-11-17T05:09:38ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S114S11510.1192/j.eurpsy.2023.311A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depressionL. Larini0M. Castiglioni1E. Piccoli2C. Scarpa3M. Renne4S. Torriero5M. Bosi6B. Benatti7A. Varinelli8M. Vismara9B. Dell’Osso10Psychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco HospitalPsychiatry 2 Unit, Luigi Sacco Hospital “Aldo Ravelli” Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, United States Introduction Repetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment and rTMS protocols have been included in international guidelines for patients with treatment-resistant depression (TRD). The daily administration of standard rTMS protocols, typically over several weeks, could be a limiting factor (e.g., time off from work, commuting issues). To intensify the antidepressant response and to reduce the number of stimulation days, it has been proposed that increasing the number of rTMS sessions performed per day could be more effective and help to reduce the burden for patients and clinicians. Although there is much interest in accelerated TMS protocols, little is known about their efficacy and tolerability, and the literature on the topic is still scarce. Objectives To compare the efficacy and tolerability of two rTMS protocols (standard vs. accelerated) as augmentative strategies in patients with TRD. Methods In the present ongoing, open-label, trial 14 patients meeting DSM-5 criteria for major depressive episode (either unipolar or bipolar), classified as partial responders or non-responders to adequate pharmacological treatment, were randomized to receive either standard (one session per day, five days a week, for four weeks; n= 7) or accelerated (two sessions per day, five days a week, for two weeks; n=6) rTMS treatment protocols. In both cases, rTMS was performed on the left dorsolateral prefrontal cortex, high frequency (10 Hz) at 120% of the motor threshold, 3000 pulses per sessions. Primary outcome measures included HAM-D, MADRS, and CGI-S scores at baseline (T0), at the end of rTMS treatment (T1), and after 1 month (T2), as well as tolerability based on adverse effects. Paired Samples t-Test for continuous variables was used to compare psychometric scales at each timepoint, while t-Test was used to compare differences between the two groups. Results With respect to total sample, in terms of primary outcome measures a significant reduction of HAM-D, MADRS and CGI-S total scores between T0 and T1 (t: 3.01, p<0.05; t: 1.692, p<0.5; t:3.207, p<0.05 respectively), T1 and T2 (t: 3.264, p<0.05: t:2.669, p<0.05; t:.085, p=0.437 respectively) and T0 and T2 (t:5.669, p<0.05; t=4.711, p<0.05; t:2.551, p<0.05 respectively) was found. No significant differences in terms of efficacy were found between the two groups. One patient dropped-out for reasons not related to rTMS treatment. Mild and transient headache during the stimulation was the only side effect reported (4 patients). Image: Conclusions Consistently with previous literature studies, our preliminary results supported the evidence of comparable efficacy and tolerability between accelerated and standard rTMS protocols. In the future, larger, blinded, and controlled trials might support these conclusions and further address treatment parameters of novel accelerated rTMS protocols. Disclosure of InterestNone Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823003115/type/journal_article |
| spellingShingle | L. Larini M. Castiglioni E. Piccoli C. Scarpa M. Renne S. Torriero M. Bosi B. Benatti A. Varinelli M. Vismara B. Dell’Osso A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression European Psychiatry |
| title | A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression |
| title_full | A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression |
| title_fullStr | A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression |
| title_full_unstemmed | A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression |
| title_short | A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression |
| title_sort | comparison between two rtms protocols as augmentation strategies in patients with treatment resistant depression |
| url | https://www.cambridge.org/core/product/identifier/S0924933823003115/type/journal_article |
| work_keys_str_mv | AT llarini acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mcastiglioni acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT epiccoli acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT cscarpa acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mrenne acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT storriero acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mbosi acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT bbenatti acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT avarinelli acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mvismara acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT bdellosso acomparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT llarini comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mcastiglioni comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT epiccoli comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT cscarpa comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mrenne comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT storriero comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mbosi comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT bbenatti comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT avarinelli comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT mvismara comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression AT bdellosso comparisonbetweentwortmsprotocolsasaugmentationstrategiesinpatientswithtreatmentresistantdepression |